Get Real: Orbital’s Chris Bunniss On Real World Evidence’s Potential For OTC Innovation
Can "real world evidence" drive consumer health innovation? HBW Insight speaks to Orbital Research’s Chris Bunniss about RWE’s potential for the OTC industry.
You may also be interested in...
HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe.
Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy.
The European Medicines Agency commits to exploring real-world data as part of its new Regulatory Science Strategy to 2025.